Frequency of cross-resistance to rilpivirine and etravirine among HIV-1 subtype C infected individuals failing nevirapine/efavirenz based ART regimen

Infect Dis (Lond). 2019 Jan;51(1):71-74. doi: 10.1080/23744235.2018.1510182. Epub 2018 Oct 29.

Authors

V V Ramalingam¹, J P Demosthenes¹, B C Ghale¹, P Rupali², G M Varghese², O C Abraham³, R Kannangai¹

Affiliations

¹ a Department of Clinical Virology , Christian Medical College , Vellore , India.
² b Department of Infectious Diseases , Christian Medical College , Vellore , India.
³ c Department of Medicine , Christian Medical College , Vellore , India.

PMID: 30371136
DOI: 10.1080/23744235.2018.1510182

No abstract available

Publication types

Letter
Comment

MeSH terms

Alkynes
Benzoxazines
Cyclopropanes
HIV Infections*
HIV-1*
Humans
Nevirapine
Nitriles
Pyridazines*
Pyrimidines
Rilpivirine
Sweden

Substances

Alkynes
Benzoxazines
Cyclopropanes
Nitriles
Pyridazines
Pyrimidines
etravirine
Nevirapine
Rilpivirine
efavirenz